Department of Diagnostic Sciences and Oral biology , College of Dentistry, King Khalid University, Abha, Kingdom of Saudi Arabia.
Department of Periodontology, Mamata Dental College, Khammam, India.
BMC Oral Health. 2018 Dec 27;18(1):227. doi: 10.1186/s12903-018-0690-4.
Gingival enlargement due to calcium channel blockers is a common complaint reported by patients. It can be localized or generalized and can range from mild to severe, affecting patients appearance and function. Nifedipine induced gingival enlargement is noticed only in 10 % of patients and very few cases of Nifedipine induced gingival enlargement in an edentulous patient have been documented in the literature.
Here in, we report a case of gingival enlargement in a 70 year old hypertensive edentulous patient who was on low dose Nifedipine therapy. Patient wanted complete dentures. We planned to excise the overgrowth and followed up for 1 year.
Nifedipine induced gingival enlargement noticed only in 10 % of patients. Hence, there is a need for physicians and dentist to make a coordinated treatment plan and practice care while prescribing these drugs which are associated with gingival overgrowth.
钙通道阻滞剂引起的牙龈增生是患者常报告的一种常见问题。它可以是局部的或广泛的,可以从轻度到重度,影响患者的外观和功能。硝苯地平引起的牙龈增生仅在 10%的患者中被注意到,并且文献中很少有记录在案的无牙患者中硝苯地平引起的牙龈增生的病例。
在这里,我们报告了一例 70 岁高血压无牙患者的牙龈增生病例,该患者正在接受低剂量硝苯地平治疗。患者需要全口义齿。我们计划切除过度生长的组织,并进行了 1 年的随访。
硝苯地平引起的牙龈增生仅在 10%的患者中被注意到。因此,医生和牙医在开具这些与牙龈过度生长相关的药物时,需要制定协调的治疗计划并进行护理。